Serum transferrin receptor-ferritin index as a marker of iron deficiency anemia in active inflammatory bowel disease patients in Indian population
DOI:
https://doi.org/10.18203/2320-6012.ijrms20213425Keywords:
Ulcerative colitis, Crohn’s disease, AnemiaAbstract
Background: Anemia is most common complication in IBD (inflammatory bowel disease). The aim of the study was to assess the sTfR-F (soluble transferrin receptor-ferritin) index as early marker of IDA (iron deficiency anaemia) in IBD.
Methods: Retrospective cross sectional study has 480 cases of IBD (group I ) with controls 220 (group II), CBP, serum hsCRP, serum iron, TIBC (total iron binding capacity), sTfR, ferritin, fecal calprotectin, vitamin B12, folic acid were assessed.
Results: In study I, group I was compared with group II showed (66.5%) patients had active disease and in that 65.0% of UC, 32.1% of CD and 2.9% others colitis had anemia. In study II, subgroup I 56.4% had IDA subgroup II 7.3% had ferritin between 30-100 ng/ml combi subgroup III 23.3% had ferritin>100 ng/ml (ACD, anaemia of chronic disease) subgroup IV 5.6% had vitamin B12 and folic acid deficiency excluding sTfR-F analysis. In study III, subdivided to identify IDA with sTfR-F index as group A 60.8% had sTfR-F index>2, group B 32.6% had sTfR-F index=1-2 and group C 3 (6.2%) had sTfR-F index<1. Intially diagnosed IDA was 56.4%, in addition with group A, IDA has increased by 66.5%. In study IV, in IDA, sensitivity of sTfR-F index was100%, sTfR 89% and SF 85%. Specificity of sTfR and sTfR-F index were 80.60% and SF has low specificity 73.90%. In study V, a statistical significance was seen more in female than male and in children than in adults with sTfR-F index in IDA.
Conclusions: sTfR-F index as an early diagnostic marker, in differentiating IDA, ACD and combi in IBD patients.
References
Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066-78.
Antunes CV, Neto AEH, Nascimento CR, Chebli LA, Moutinho IL, Bdo VP, et al. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int. 2015;2015:728925.
Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, et al. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study. Scand J Gastroenterol. 2013;48(11):1286-93.
Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211-22.
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907-16.
Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis. 2011;5(5):381-91.
Portela F, Lago P, Cotter J, Gonçalves R, Vasconcelos H, Ministro P, et al. Anaemia in patients with inflammatory bowel disease-a nationwide cross-sectional study. Digestion. 2016;93(3):214-20.
Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010;95(2):175-8.
Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7(11):599-610.
Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med. 1992;119(4):385-90.
Baynes RD, Shih YJ, Hudson BG, Cook JD. Production of serum form of transferrin receptor by a cell membrane associated serine protease. Proc Soc Exp Biol Med. 1993;204(1):65-9.
Organization WH, Organization WH. Indicators and strategies for iron deficiency and anemia programmes. Report of the WHO/UNICEF/UNU consultation 1994; 6-10. Available at: http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf. Accessed on 20 July 2021.
Santen SV, Dongen-Lases ECV, Vegt FD, Laarakkers CMM, Riel PLCMV, Ede AEV, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 2011;63(12):3672-80.
Dimitrou H, Stiakaki E, Markaki EA. Soluble transferring receptor levels and soluble transferrin receptor/ log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy. Acta Paediatr. 2000;89(10):1169-73.
Lopez MAV, Molonis FL, Carmona ML, Morales AC, Vico FJM, Munoz JL, et al. Serum transferrin receptor in children: usefulness for determining the nature of anemia in children. J Pediatr Hematol Oncol. 2006;28(12):809-15.
Malope BL, MacPhail AP, Alberts M, Hiss DC. The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status. Br J Haematol. 2001;115(1):84-9.
Hanif E, Ayyub M, Anwar M, Ali W, Bashir M. Evaluation of serum transferrin receptor concentration in diagnosis and differentiating iron deficiency anemia from anem ia of chronic disorders. J Pak Med Assoc. 2005;55(1):13-6.
Cairo G, Recalcati S. Iron-regulatory proteins: Molecular biology and patho-physiological implications. Expert Rev Mol Med. 2007;9:1–13.
Worwood M. Serum transferrin receptor assays and their application. Ann Clin Biochem. 2002;39(3):221-30.
Petterson T, Kivivuori SM, Siimes MA. Is serum transferrin receptor useful for detecting iron deficiency inn anemic patients with chronic inflammatory disease. Br J Rheumatol. 1994;33(8):740-4.
Goldenberg BA, Graff LA, Clara I, Zarychanski R, Walker JR, Carr R, et al. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease? Am J Gastroenterol. 2013;108(9):1392-7.
Högberg C, Karling P, Rutegård J, Lilja M. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: the usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study. Scand J Gastroenterol. 2017;52(1):69-75.
Narzo AFD, Telesco SE, Brodmerkel C, Argmann C, Peters LA, Li K, et al. High-throughput characterization of blood serum proteomics of IBD patients with respect to aging and genetic factors. PLoS Genet. 2017;13(1):1006565.
Herrera-deGuise C, Casellas F, Robles V, Navarro E, Borruel N. Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(6):1450-5.
Abitbol V, Borderie D, Polin V, Maksimovic F, Sarfati G, Esch A, et al. Diagnosis of iron deficiency in inflammatory bowel disease by transferrin receptor-ferritin index. Medicine (Baltimore). 2015;94(26):1011.
Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011;46(3):304-9.
Norberg M, Wall S, Boman K, Weinehall L. The Västerbotten Intervention Programme: background, design and implications. Glob Health Action. 2010;3:1-15.
Punnomen K, Irjala K, Rajamaki A. Iron deficiency anemia is associated with high concentration of transferring receptor in serum. Clin Chem. 1994;40(5):774-6.
